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Targeted irreversible inhibitors bearing electrophiles that become activated towards covalent bond for-
mation upon binding to a specific protein/enzyme is an emerging area in drug discovery. Targeting lysine
residues is challenging due to the intrinsically low reactivity of the amino group at physiological pH.
Herein we report the first example of a hydroxylammonium derivative that causes a specific covalent
modification of an active-site and a sterically inaccessible lysine residue of an enzyme. The described
ligands, compounds 1–3, were rationally designed to be activated towards covalent bond formation upon
binding to the type I dehydroquinase (DHQ1) enzyme for the development of new anti-virulence agents
to combat the widespread resistance to antibiotics. Evidence in atomic detail for the covalent modifi-
cations caused by the ligands to the catalytic Lys170 by the formation of a stable secondary amine is pro-
vided by the resolution at 1.08–1.25 Å of the crystal structures of DHQ1 from Salmonella typhi enzyme
adducts. In addition, the first crystal structure of the addition intermediate adduct at 1.4 Å of a Schiff base
formation reaction by using an analog of the natural substrate, compound 4, is also reported. Molecular
dynamics simulation studies on non-covalent enzyme/ligand complexes and a two-dimensional QM/MM
umbrella sampling simulation study suggested that a direct displacement by Lys170 with the release of
NH2OH would be feasible. These studies might open up new opportunities for the development of novel
lysine-targeted irreversible inhibitors bearing a methylhydroxylammonium moiety as a latent electrophile.
Introduction
Targeting infectious diseases and cancer with small molecules
that covalently modify the target is an emerging area in drug
discovery.1–9 The more detailed knowledge available today on
the real risks associated with this type of compound, as well as
its enormous advantages (efficacy, selectivity, and lower sus-
ceptibility to resistance mechanisms), has led to a dramatic
increase in their presence in anti-infective and oncology dis-
covery programs in recent years.10 Besides these advantages,
the development of this type of ligand represents a huge chal-
lenge due to the need to combine reactivity (covalent modifi-
cation) and selectivity (safety) in a single chemical entity. This
indicates the use of ligands bearing weak electrophilic groups
which are able to achieve potency without sacrificing selecti-
vity. In recent years, efforts have been devoted to the design of
irreversible compounds capable of modulating their reactivity
when complementarity with the specific target takes place.8
These are targeted irreversible inhibitors bearing electrophiles
which become activated towards covalent bond formation
upon binding to a specific protein or enzyme. The intrinsically
low chemical reactivity of these ligands makes them particu-
larly desirable for drug development since they would be
hidden to non-specific targets and are only activated for the
chemical modification reaction upon binding. The majority of
these ligands have been designed to modify cysteine residues.
Relevant examples include fluoromethylketones, terminal
alkynes, acrylamides, and disulfides (Fig. 1A).11–18 Targeting
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lysine residues appears more challenging because their
ε-amino group is usually non-nucleophilic as it is protonated
at physiological pH.19 Remarkable examples include aromatic
sulfonyl fluorides, vinyl sulfones, aryl fluorosulfates and
nitriles (Fig. 1B).20–26 The selective modification of active-site
lysine residues is more affordable, because they either have a
lower pKa or their nucleophilicity/basicity is modulated by
other amino acid residues (Asp and His) in the vicinity, which
might also participate in the catalysis.
We became interested in the design of ligands able to cause
the covalent modification of the type I dehydroquinase
(DHQ1) enzyme. DHQ1 is an aldolase (dehydratase) enzyme
that does not have any counterpart in human cells, and has
been pinpointed as a promising target in the search for new
anti-virulence agents.27 It is believed that DHQ1 may act as a
virulence factor in vivo since the deletion of the aroD gene,
which encodes DHQ1 from Salmonella typhi and Shigella
flexneri, has been proven to afford satisfactory live oral
vaccines.28–30 Targeting the bacterial capacity to produce infec-
tion (virulence), rather than the most widely used disruption
of bacterial survival, is an innovative strategy which is increas-
ingly being explored to combat the worldwide increasing
appearance of “superbugs” (multi-drug resistant bacteria),
which are resistant to most antibiotics in clinical use.
Compounds that target bacterial virulence signalling pathways
would create an in vivo scenario similar to vaccination with a
live attenuated strain in which the bacteria are eventually
cleared by the host immune system. DHQ1 is present
in several pathogenic bacteria such as Escherichia coli,
Staphylococcus aureus and Salmonella typhi. This enzyme,
which is a dimer, has 8 lysine residues in each chain and cata-
lyzes the reversible syn dehydration of water in 3-dehydroqui-
nic acid to form 3-dehydroshikimic acid by a multi-step
mechanism which involves the formation of Schiff base
species.31
We report here the use of hydroxylammonium derivatives,
compounds 1–3, for the specific covalent modification of the
catalytic lysine residue of DHQ1 from S. typhi (St-DHQ1)
(Fig. 1C). Evidence in atomic detail of the covalent modifi-
cations caused by compounds 1–3 to the essential Lys170 by
the formation of a stable amine is provided by the resolution
of high quality crystal structures of St-DHQ1 (resolution range:
1.08–1.25 Å) chemically modified by 1–3. The reported com-
pounds were also designed to provide non-labile enzyme
adducts by being able to avoid the intrinsic dehydration reac-
tion performed by the enzyme. The chemical basis of the latter
was inspired by the herein reported Molecular Dynamics (MD)
simulation studies on the Michaelis and substrate Schiff base
complexes, as well as by the resolution for the first time of the
crystal structure of the addition intermediate adduct at 1.4 Å
of the substrate Schiff base formation reaction of St-DHQ1 by
using an analog of the natural substrate, compound 4.
Results and discussion
Ligand design
It has been proposed that the reaction catalyzed by DHQ1 is
initiated by the activation of the C3 carbonyl group of the sub-
strate from the Re face by the essential His143, and subsequent
nucleophilic attack of the ε-amino group of the essential
Lys170 from the opposite face to afford initially the addition
intermediate adduct (Fig. 2A).32 It has been shown previously
that epoxide 6 causes the chemical modification of St-DHQ1
by the formation, after dehydration, of a Schiff base with the
essential Lys170, adduct II (Fig. 2B).32 This process was evi-
denced by the resolution of the crystal structure of the St-
DHQ1/6 adduct obtained by co-crystallization (PDB entry
4CLM). On the other hand, derivative 5 proved to cause the
covalent modification of Lys170 through the initial formation
of an amine, adduct I, as revealed by the crystal structure of
the enzyme adduct obtained by soaking apo-St-DHQ1 crystals
for 30 s (PDB entry 4UIO).33 In solution, this initial adduct I
Fig. 1 Selected examples of latent electrophiles and targeted ligands. (A and B) Latent electrophiles for modification of cysteine (A) and lysine resi-
dues (B). The position that is covalently modified is indicated with an asterisk. (C) Designed quinic acid-based hydroxylammonium compounds 1–3
and substrate analog 4. The chemical modifications of the catalytic Lys170 of DHQ1 from S. typhi identified by X-ray crystallography are also shown.
Research Article Organic Chemistry Frontiers
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undergoes a dehydration reaction to afford also the imine
adduct II (S. typhi).
Considering that the formation of an imine group does not
represent the best scenario for disabling a target, even taking
into account that it proved to be a very stable Schiff base, our
efforts were devoted to not only exploring the potential of a
methylhydroxylammonium group as a novel latent electro-
phile, but also avoiding possible dehydration processes by
using another type of covalent linkage with the protein. The
hydroxylammonium group was chosen because: (i) in MD
simulation studies on the St-DHQ1/5 complex, it was observed
that the ammonium group in 5 establishes, during a signifi-
cant part of the simulation, a weak electrostatic interaction
(∼3.4 Å) with the conserved Asp114 residue (Fig. 2C); and (ii)
the incorporation of an OH group in the leaving group would
enhance the latter interaction and therefore would fix the
arrangement of the side chain for nucleophilic attack by
Lys170 from the opposite site.
Moreover, MD simulation studies carried out with the
addition intermediate adduct revealed that the C3 hydroxyl
group in the latter adduct remained fixed during the whole
simulation (50 ns) with the proton engaged in an intra-
molecular hydrogen bond with one of the oxygen lone pairs of
the C1 hydroxyl group and with one of the oxygen lone pairs
accepting a hydrogen bond from the guanidinium group of
Arg48 (Fig. 2D and S1†). The C1 hydroxyl group seems to be
therefore employed by DHQ1 to achieve the appropriate
arrangement of the C3 hydroxyl group for an effective sub-
sequent dehydration reaction to afford the substrate Schiff
base. Reasoning that the dehydration reaction would be disfa-
vored by using compounds lacking the tertiary C1 hydroxyl
group, compound 4 was synthesized for structural studies that
could confirm this hypothesis.
Synthesis of ligands 1–4
Ligand 4 was prepared as outlined in Fig. 3A. Firstly, hydroge-
nolysis of the protected 3-epi-shikimic acid 7 34 afforded com-
pound 8 diastereoselectively. It is important to highlight that
having the S configuration in the secondary alcohol is crucial
to achieve good stereocontrol of the reduction from the Re face
of the double bond. The configuration of the new chiral center
in 8 was confirmed by the coupling constants in the corres-
ponding 1H NMR spectra (Fig. S2†). Basic hydrolysis of 8 fol-
lowed by alkylation with benzyl bromide gave ester 10.
Oxidation of 10 using Dess–Martin periodinane followed by
acid hydrolysis of the acetal group in 11 and final hydrogenoly-
sis of the resulting benzyl ester 12 gave acid 4.
Compound 1 was synthesized from aldehyde 18, which was
prepared in four steps from alcohol 8 (Fig. 3B). Firstly, PDC-
oxidation of 8 followed by nucleophilic addition of vinyl mag-
nesium bromide to the resulting ketone 13 gave diastereoselec-
tively the vinyl derivative 16. The regioselectivity of the reaction
was confirmed by NOE experiments. Inversion of the signal of
H6 led to an enhancement of the signal for the H1′ vinyl group
(3.1%). Having observed that the ozonolysis of alkene 16
afforded complex reaction mixtures and a very low yield of the
desired compound, protection of the tertiary alcohol in 16 as a
trimethylsilyl ether was carried out. In this way, ozonolysis of
the resulting protected alkene 17 and subsequent reductive
workup using dimethyl sulfide gave the desired aldehyde 18.
Finally, reductive amination of aldehyde 18 with hydroxyl-
amine followed by hydrolysis of methyl ester 19 under acidic
conditions with concomitant removal of the protecting groups
led to the target compound 1.
Compounds 2 and 3 were prepared from previously
reported alkene 15 32 and compound 14 using aldehydes 22
and 24 as key intermediates, respectively (Fig. 3B). Alkene 14
was synthesized by methylenation of the ketone 15.
Subsequent conversion of the alkenes 15 and 14 to the
required aldehydes 22 and 24, respectively, was achieved in
two steps. Firstly, hydroboration–oxidation took place from the
less hindered Si face of the external double bond to afford
compounds 20 and 21 diastereoselectively, both of which have
the CH2OH group in the axial disposition. Secondly, oxidation
of the primary alcohols in 20 and 21 using Dess–Martin peri-
odinane or PDC with subsequent full epimerization to the
thermodynamic equatorial aldehydes by heating in the pres-
ence of pyridine gave the desired aldehydes 22 and 24, respect-
ively. The stereochemistry of the new chiral center created in
compounds 20–22 and 24 was confirmed by the coupling con-
Fig. 2 Mechanistic and structural basis for ligand design. (A) Reaction
catalyzed by DHQ1. The role of the essential residues Lys170 and His143
in the formation of the substrate-Schiff base in the enzymatic mecha-
nism is shown. (B) Chemical modification of St-DHQ1 by 5 and 6 ident-
ified by X-ray crystallography. (C) Arrangement of 5 relative to Asp114.
(D) Substrate addition intermediate adduct after 50 ns of dynamic simu-
lation (yellow) obtained by computational studies.
Organic Chemistry Frontiers Research Article
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stants in the corresponding 1H NMR spectra and by NOE
experiments (Fig. S2†). Finally, aldehydes 22 and 24 were con-
verted to the target derivatives 2 and 3 in the same way as that
for compound 1 from aldehyde 18.
X-ray crystal structures of St-DHQ1/1–4 adducts
St-DHQ1/4 adduct. The X-ray crystal structure of the St-
DHQ1/4 adduct was obtained by soaking apo-St-DHQ1 crystals
and the structure was solved at 1.4 Å (Fig. 4). Crystals were
mounted into cryoloops and were directly flash frozen by rapid
immersion in liquid nitrogen. X-ray diffraction data were col-
lected from crystals cryo-cooled in a stream of cold nitrogen
gas (100 K) at ambient pressure using synchrotron radiation
and the data were subsequently processed. The structure was
determined by molecular replacement, using the previously
described structure of the reduced form of the St-DHQ1
product–Schiff base intermediate (PDB entry 1QFE28) as a
search model, and the structure was refined. A summary of the
statistical data following data reduction and processing is pro-
vided in Table S1.†
Unbiased, calculated electron density maps showed clear
and high quality electron density for the enzyme-modified
ligand molecule 4. The structure revealed that the addition
adduct of the ε-amino group of the Lys170 residue and the
ketone group in 4 was obtained and, more importantly, de-
hydration of the C3 hydroxyl group did not take place since
clear electron density was observed for this hydroxyl group.
The NZ atom of the modified Lys170 residue establishes a
strong interaction with the conserved residue Asp114 via a
water molecule (structural, W23) – an interaction that is found
in all related crystal structures reported previously. The essen-
tial His143 residue interacts by hydrogen bonding with the
C3 hydroxyl group of the modified ligand. In addition, the
C3 hydroxyl and the C1 carboxylate groups of the modified
ligand are linked via bridges involving water molecules (W81
and W104). The modified ligand is also anchored to the active
site by the same type of electrostatic and hydrogen bonding
interactions as the natural substrate, specifically, residues
Gln236 and Ser232 (substrate-covering loop), and Arg213,
Ser21, Arg48, Arg82 and Glu46.
Moreover, MD simulation studies carried out with the
addition intermediate adduct St-DHQ1/4 clearly showed that
the oxygen lone pairs of the C3 hydroxyl group would not be
engaged by the guanidinium group of Arg82 (Fig. S3†). Thus,
this group would rotate freely, and the guanidinium group of
Arg82 would mainly interact with the C4 hydroxyl group of the
modified ligand 4 instead of interacting with its C3 hydroxyl
group. During the simulation, a large variability of the di-
Fig. 3 Synthesis of compounds 4 (A) and 1–3 (B). Reagents and conditions: (a) H2 (g), Pd/C (10%), MeOH, RT. (b) 1. LiOH, THF, RT; 2. Amberlite
IR-120 (H+). (c) 1. E3N, DMAP, Bu4NI, DMF, RT; 2. BnBr, RT. (d) Dess–Martin periodinane, DCM, RT. (e) TFA/H2O (20 : 1), RT. (f ) H2, Pd/C (10%), EtOAc,
RT. (g) PDC, 4 Å MS, DCM, RT. (h) Zn dust, CH2I2, TiCl4, THF, 0 °C. (i) CH2vCHMgBr, THF, −78 °C. ( j) TMSCl, (TMS)2NH, Py, RT. (k) 1. O3, DCM,
−78 °C. 2. SMe2, −78 °C. (l) 1. NH2OH.HCl, NaOAc, 4 Å MS, MeOH, RT; 2. NaBH3CN, MeOH, RT. (m) HCl (0.3 M), 100 °C. (n) 1. BH3-THF, THF, 0 °C;
2. NaBO3. (o) for 20 : 1. Dess–Martin periodinane, DCM, RT; 2. Py, MeOH, 60 °C. (p) for 21 : 1. PDC, 4 Å MS, DCM, RT; 2. Py, MeOH, 60 °C.
Research Article Organic Chemistry Frontiers
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hedral angle among the C2, C3, O3 and HO3 atoms of the
modified ligand 4 is observed (Fig. S3C†). When the same ana-
lysis was carried out with the addition intermediate adduct
obtained with the natural substrate, which has a hydroxyl
group in C1 (Fig. S1C†), no rotation of the C3 hydroxyl group
was observed as its oxygen lone pairs were held by Arg82
(Fig. 2D). Furthermore, the ε-nitrogen atom of the modified
Lys170 by the modified natural substrate would be in an
appropriate anti-periplanar arrangement for subsequent de-
hydration to afford the substrate-Schiff base. Thus, during the
simulation the average value of the dihedral angle among the
O3, C3, NZ and CE atoms of the modified substrate would be
−61.8° (Fig. S4†). A less efficient anti-periplanar conformation
was observed in the modified ligand 4, since the latter di-
hedral angle has a value of −68.1° in the crystal structure and
an average value of −72.6° during the simulation (Fig. S4†).
Taken together, the results of our structural and compu-
tational studies confirm our hypothesis about the key role of
the C1 hydroxyl group in controlling the correct arrangement
of the generated C3 hydroxyl group in the addition intermedi-
ate adduct for dehydration to afford the substrate-Schiff base.
St-DHQ1/1–3 adducts. The crystal structures of St-DHQ1/1–3
adducts were obtained by co-crystallization (4 weeks) and the
structures were solved at high resolutions of 1.25, 1.04 and
1.14 Å, respectively (Fig. 5). The structures were determined by
molecular replacement, using the previously described struc-
tures of St-DHQ1 (PDB entries 4UIO and 4CNO) as search
models, and the resulting structures were refined. See the
Experimental section and Table S1† for further details. For all
cases, unbiased, calculated electron density maps revealed
clear and well-defined electron density for the enzyme-modi-
fied ligand molecules 1–3, with the covalent modification of
Lys170 through the formation of an amine. It is noteworthy
that for ligand 1, which is the only one that has a hydroxyl
group in the C3 position, dehydration reactions did not take
place as clear electron density for the C3 hydroxyl group was
observed. In contrast to the St-DHQ1/4 adduct, for St-DHQ1/
1–3 adducts, a strong interaction between the His143 side
chain and the NZ atom of the modified Lys170 residue (dis-
tance: 2.8–2.9 Å measured between heavy atoms) is observed
regardless of the presence or absence of a hydroxyl group at C3
of the modified ligand. In addition, an interaction between the
modified Lys170 and the carboxylate side chain of Asp114 via
the structural water molecule was not observed. In general, the
rest of the interactions involving the C4 and C5 hydroxyl
groups and the C1 carboxylate group are similar to those
observed in the St-DHQ1/4 adduct. Moreover, Kleanthous
et al.35 reported that the covalent attachment of the reaction
product molecule (as reduced from a secondary amine) to DHQ1
from Escherichia coli, which was revealed to have a melting
temperature 40 °C higher than that of the unmodified protein,
causes a dramatic increase in the stability of the protein
against proteolysis. A similar behavior would be expected for
the reported chemically modified St-DHQ1 enzyme.
Inhibition studies
The capacity of the reported hydroxylammonium derivatives to
cause the irreversible inhibition of the DHQ1 enzyme from
S. typhi (St-DHQ1) and S. aureus (Sa-DHQ1) was analyzed by
incubation of both enzymes with ligands 1–3 for a 24 h period
(PPB, pH 7.0, 25 °C). The activity was progressively determined
by UV spectroscopy under the standard assay conditions using
aliquots from the incubation samples and the control. The
ligands 1–3 were found to be slow time-dependent irreversible
inhibitors of the two enzymes (Fig. S5†). The inactivation
proved to be more efficient for Sa-DHQ1 than for St-DHQ1. For
the S. typhi enzyme, compound 2 proved to be the most
efficient of the three ligands (4 h, ∼50% inactivation,
∼@1 : 120 enzyme/ligand ratio), whereas compound 1 was for
Fig. 4 Crystal structure of St-DHQ1 covalently modified by 4. (A) Overall view of the structure of St-DHQ1 covalently modified by 4. (B) Unbiased
electron density for the modified ligand 4 (yellow) and its covalent attachment to Lys170 (green) of St-DHQ1 (gray). A maximum-likelihood weighted
2Fo − Fc map contoured at 1σ is shown up to 1.6 Å around the ligand molecule. The final model, including the ligand molecule, is superimposed
onto the map. (C) Interactions of the modified ligand 4 with St-DHQ1. Hydrogen bonding and electrostatic interactions between the ligand and
St-DHQ1 are shown as dashed lines. Relevant residues and water molecules and distances are shown and labeled.
Organic Chemistry Frontiers Research Article
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Sa-DHQ1 (2.5 h, ∼50% inactivation, ∼@1 : 120 enzyme/ligand
ratio).
Computational studies
The binding modes of ligands 1–3 in the active site of
St-DHQ1 were first studied by molecular docking using the
program GOLD 5.2.236 and further analyzed by MD simulation
studies (100 ns). The monomer of the binary St-DHQ1/1–3
protein complexes in a truncated octahedron of water mole-
cules obtained with the molecular mechanics force field
AMBER was employed. These simulation studies were carried
out considering the two possible protonation states of His143
(δ and dual). However, the latter possibility (dual) was ruled
out because it caused an opening of the active site and a dis-
placement of the ligands. The results revealed that the con-
served Asp114 residue would be the main fragment respon-
sible for the exquisite control of the arrangement of the
leaving group and consequently of the methylene group at
which covalent modification occurs (Fig. 6A–C). In particular,
the hydroxyl group of the hydroxylammonium moiety would
facilitate the establishment of a strong and stable hydrogen
bonding interaction with the carboxylate group of Asp114. The
average distance between Asp114 (OD1 atom) and the NH2OH ̲
group (H04 atom) in 1–3 during the whole simulation was
∼1.6 Å in all cases (Fig. S6†). In addition, the hydrogen
bonding interaction of the ligand side chain with the essential
His143 would also greatly contribute towards freezing the con-
formation of the C3 side chain (Fig. S6†). Moreover, the
average distances between His143 (NE2 atom) and the NH̲2OH
group (HZ atom) in 1–3 were calculated to be ∼2.5, 2.1 and
2.3 Å, respectively. For ligands 2–3, a strong and stable hydro-
gen bonding interaction with the structural water (average dis-
tance of ∼2.1 Å) is the third contact which fixes the confor-
mation of the leaving group. This contact was not observed for
ligand 1 which seems to be caused by intramolecular hydrogen
bonding between the C3 hydroxyl group and the NH2OH group
to provide a different arrangement of the NZ atom.
In an effort to get an insight into how the reported ligands
cause the covalent modification of the catalytic lysine residue,
a combined quantum mechanics/molecular mechanics (QM/
MM) umbrella sampling simulation study was carried out.
Modelling of reactions in enzymes with QM/MM methods can
provide knowledge in atomic detail about the mechanism, the
key interactions of the ligands, reaction intermediate(s) and
transition state(s).37,38 By using these methods, the electronic
rearrangements involved in the breaking/making of chemical
Fig. 5 Crystal structures of St-DHQ1 covalently modified by 1–3. (A, B, and C) Unbiased electron density for the modified ligands 1 (A, violet),
2 (B, cyan), and 3 (C, orange), and their covalent attachment to Lys170 of St-DHQ1 (green). From the model obtained by molecular replacement and
before the inclusion of the inhibitor molecule, refinement was performed to obtain unbiased density for the inhibitor molecule and other model
changes. A maximum-likelihood weighted 2Fo − Fc map contoured at 1σ is shown up to 1.6 Å around the ligand molecule, the structural water mole-
cule, and Lys170, His143 and Asp114 side chains (gray). The final model, including the ligand molecule, is superimposed onto the map. (D, E, and F)
Interactions of the modified ligands 1 (violet), 2 (cyan), and 3 (orange) with St-DHQ1 (gray). Hydrogen bonding and electrostatic interactions
between the ligands and St-DHQ1 are shown as dashed lines. Relevant residues are shown and labeled.
Research Article Organic Chemistry Frontiers
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bonds (QM) are studied in a dynamic environment (MM)
which mimics the conformational changes of the enzyme
occurring during the reaction, which are also important for
the reaction energetics. In addition, by using umbrella
sampling techniques, the exploration of regions along the reac-
tion coordinate which would otherwise have insufficient
sampling is achieved. These QM/MM umbrella sampling simu-
lation studies were performed with compound 2 and diverse
geometries on the non-covalent binary St-DHQ1/2 complex
were obtained by MD simulation studies. Three possible reac-
tion coordinates were explored: (i) breakdown of the C–N bond
in 2; (ii) formation of the C(2)–N(K170) bond; and (iii) a linear
combination of (i) minus (ii). Two possible protonation states
of His143 (δ and dual) were employed. However, the latter
possibility (dual) was ruled out because it caused an opening
of the active site. The best results were obtained with the two-
dimensional US (iii) (see the ESI† for full details). The result-
ing free energy profile at the SCC–DFTB/ff14SB level indicates
that the SN2 nucleophilic substitution by Lys170 with the
release of NH2OH would be feasible, with an energy barrier of
27.2 kcal mol−1 for the TS (TS1), which would be the rate-deter-
mining step (Fig. 6D–G). The reaction would involve the for-
mation of an intermediate INT with an energy barrier of
11.8 kcal mol−1 which would undergo a subsequent deproto-
nation by neutral His143 having a very low reaction barrier
(0.9 kcal mol−1 relative to INT, TS2) (Fig. S7†).
Conclusions
In summary, we have demonstrated that quinic acid-based
hydroxylammonium derivatives can be used for the selective
covalent modification of the catalytic lysine residue of the
DHQ1 enzyme, which is a promising target for anti-virulence
drug discovery. This was evidenced by the resolution of the
crystal structures of DHQ1 from S. typhi (resolution range:
1.08–1.25 Å) chemically modified by the reported ligands 1–3
showing that the modified ligands are linked to the lysine
residue through an amine group. The results obtained with
compounds 2 and 3 reveal that the presence of a hydroxyl
group in position C3 of the reported scaffold is not required to
achieve covalent modification allowing the use of quite simple
ligands such as compound 3. The results from the MD and
two-dimensional QM/MM umbrella sampling simulation
studies suggested that the covalent modification mechanism
might take place by the direct nucleophilic attack of the
ε-amino group of the lysine residue with the release of NH2OH
followed by deprotonation of the lysine adduct by the essential
Fig. 6 Covalent modification mechanism of Lys170 by ligands 1–3. (A, B, and C) Proposed binding mode of ligands 1 (A, pink), 2 (B, cyan) and
3 (C, orange) in the active site of St-DHQ1 obtained by MD simulation studies. The pose of the ligands shown corresponds to that obtained after
90 ns of simulation. The side chains of the most relevant residues are shown and labeled. The residue Asp114 (green), which is key in the geometric
control of the side chain of the ligand, the essential Lys170 (red), the essential His143 (yellow) and the catalytic water, as well as the most relevant
polar interactions, are highlighted. (D, E, F, and G) QM/MM MD simulation studies for the covalent modification mechanism of St-DHQ1 by com-
pound 2. Representative geometries of TS1 (D) and intermediate INT (E). Relevant residues and water molecules are shown and labeled. Key hydro-
gen bonding interactions and bonds broken/formed (distances included) are indicated as blue and red dashed lines, respectively. The residues
Lys170 (orange) and His143 (yellow) are highlighted. Geometries were taken from the free energy surface (F). (G) Free energy profile obtained using
umbrella sampling simulations at the SCC-DFTB/ff14SB level for the whole reaction.
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histidine. To our knowledge, this is the first example of hydro-
xylammonium derivatives that cause the specific covalent
modification of a catalytic and sterically inaccessible lysine
residue of an enzyme. These studies might open up new
opportunities for the development of novel lysine-targeted ir-
reversible inhibitors bearing a hydroxylammonium moiety as a
latent electrophile.
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